A wireless photovoltaic implant shows promise in restoring central vision for patients with macular degeneration, enhancing visual acuity and independence.
A new trial will evaluate whether integrating autonomous AI screening for diabetic retinopathy into U.S. federally qualified health centers can boost screening completion and accelerate early detection. The DRES-POCAI protocol tests a real-world, point-of-care model that links FDA-cleared AI with electronic health records to close gaps in diabetes eye care.
A new study on office-based cataract surgery is challenging traditional approaches to the procedure, demonstrating that patients can undergo successful surgery with minimal oral sedation instead of with intravenous (IV) sedation at hospitals or ambulatory surgery centers.
While artificial intelligence (AI)-powered screening has been validated for diabetic retinopathy, applying the technology to glaucoma has proved more challenging because glaucoma is not one disease. A glaucoma diagnosis is based on a constellation of symptoms, diagnostic tests, and longitudinal data.
New research that sheds light on how the immune system responds to serious eye infections is underway at Wayne State University, supported by a $2.3 million federal grant from the National Eye Institute of the National Institutes of Health (NIH).
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of
our websites
and requested to be notified of additional information.
